INBRAIN Neuroelectronics (Series B)
Funding Details
Awarder
SemiNews
Date Award
April 7, 2025
Vertical
Neurotechnology
Funding URL
View Funding Page
Funding Amount
$50,000,000
Company Info
Traction
INBRAIN recently achieved a major milestone with the world’s first human application of its graphene-based BCI in an ongoing clinical trial at Salford Royal Hospital in Manchester, UK.
Organizations Involved
Merck KGaA, Salford Royal Hospital
Founders
Carolina Aguilar
Market
Healthcare
Location
Barcelona, Spain
Coinvestors
imec.xpand, EIC Fund, Fond ICO Next Tech, CDTI-Innvierte, Avançsa, Asabys Partners, Aliath Bioventures, Vsquared
Company Description

INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Neurotechnology DealsView Funding Announcement